A detailed history of Wetherby Asset Management Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Wetherby Asset Management Inc holds 5,293 shares of TECH stock, worth $422,963. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,293
Previous 5,287 0.11%
Holding current value
$422,963
Previous $372,000 1.88%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $372 - $504
6 Added 0.11%
5,293 $379,000
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $25,732 - $30,065
390 Added 7.96%
5,287 $372,000
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $258,708 - $383,043
4,897 New
4,897 $377,000
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $9,072 - $10,575
-123 Reduced 3.83%
3,092 $252,000
Q1 2023

May 12, 2023

SELL
$71.62 - $86.62 $29,006 - $35,081
-405 Reduced 11.19%
3,215 $238,000
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $229,022 - $1 Million
2,839 Added 363.51%
3,620 $300,000
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $3,390 - $4,702
12 Added 1.56%
781 $222,000
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $10,325 - $14,388
32 Added 4.34%
769 $267,000
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $12,030 - $16,584
34 Added 4.84%
737 $319,000
Q4 2021

Feb 14, 2022

SELL
$456.15 - $525.06 $34,667 - $39,904
-76 Reduced 9.76%
703 $364,000
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $23,578 - $28,560
-53 Reduced 6.37%
779 $377,000
Q2 2021

Aug 16, 2021

BUY
$387.35 - $450.26 $322,275 - $374,616
832 New
832 $375,000
Q1 2021

May 14, 2021

SELL
$314.62 - $411.0 $331,294 - $432,783
-1,053 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$246.9 - $321.87 $3,456 - $4,506
14 Added 1.35%
1,053 $334,000
Q3 2020

Nov 13, 2020

BUY
$232.22 - $282.96 $241,276 - $293,995
1,039 New
1,039 $257,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.13B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.